Collagen fillers in facial aesthetic surgery

Facial Plastic Surgery

Volumn 20, Issue 2, 2004, Pages 117-123

  Douglas, Raymond S ^a,b,c   Donsoff, Irene ^d   Cook, Todd ^c   Shorr, Norman ^a,c  

^a Shorr Douglas FACE Institute   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c JULES STEIN EYE INSTITUTE   (United States)

^d NONE

Author keywords

Collagen; Hyaluronic acid; Rhytids

Indexed keywords

COLLAGEN; FILLER; HYALURONIC ACID; LOW MOLECULAR WEIGHT HEPARIN; STEROID;

ABSCESS; ARTERY EMBOLISM; CONNECTIVE TISSUE; COW; EDEMA; EXTRACELLULAR MATRIX; FACE SURGERY; HUMAN; IMPLANT; NONHUMAN; REVIEW; SKIN DEFECT; SKIN NODULE; SKIN ULCER; SOFT TISSUE; TISSUE; WRINKLE;

ANIMALS; BIOCOMPATIBLE MATERIALS; CATTLE; COLLAGEN; FEMALE; HUMANS; HYALURONIC ACID; INJECTIONS, INTRADERMAL; RHYTIDOPLASTY; SKIN AGING;

EID: 11344287515     PISSN: 07366825     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-861751     Document Type: Review

References (28)

1. Skouge J, Diwan R. Soft tissue augmentation with injectable collagen. In: Papel I, Nachlas N, eds. Facial Plastic and Reconstructive Surgery. St Louis: Mosby Year Book; 1992:203-212
2. Clark DP, Hanke CW, Swanson NA. Dermal implants: safety of products injected for soft tissue augmentation. J Am Acad Dermatol 1989;21(5 Pt 1):992-998
3. Burgess LP, Goode RL. Injectable collagen. Facial Plast Surg 1992;8:176-182
4. Pollack SV. Silicone, fibrel, and collagen implantation for facial lines and wrinkles. J Dermatol Surg Oncol 1990;16:957-961
5. DeLustro F, Smith ST, Sundsmo J, et al. Reaction to injectionable collagen: results in animal models and clinical use. Plast Reconstr Surg 1987;4:581-589
6. Fagien S. Facial soft-tissue augmentation with injectable autologous and allogeneic human tissue collagen matrix (autologen and dermalogen). Plast Reconstr Surg 2000;105:362-373 (discussion 74-75)
7. Sclafani AP, Romo T III, Parker A, et al. Autologous collagen dispersion (Autologen) as a dermal filler: clinical observations and histologic findings. Arch Facial Plast Surg 2000;2:48-52
8. Engstrom-Laurent A. Hyaluronan in joint disease. J Intern Med 1997;242:57-60
9. Lee JY, Spicer AP. Hyaluronan: a multifunctional, mega-Dalton, stealth molecule. Curr Opin Cell Biol 2000;12:581-586
10. Sutherland IW. Novel and established applications of microbial polysaccharides. Trends Biotechnol 1998;16:41-46
11. Laurent TC, Fraser JR. Hyaluronan. FASEB J 1992;6:2397-2404
12. Goa KL, Benfield P. Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing. Drugs 1994;47:536-566
13. Kumari K, Weigel PH. Molecular cloning, expression, and characterization of the authentic hyaluronan synthase from group C Streptococcus equisimilis. J Biol Chem 1997;272:32539-32546
14. Piacquadio D. Crosslinked hyaluronic acid (hylan gel) as a soft tissue augmentation material: a preliminary assessment. In: Elson M, ed. Evaluation and Treatment of the Aging Face. New York: Springer-Verlag; 1994:174-178
15. Piacquadio D, Jarcho M, Goltz R. Evaluation of hylan b gel as a soft-tissue augmentation implant material. J Am Acad Dermatol 1997;36:544-549
16. Olenius M. The first clinical study using a new biodegradable implant for the treatment of lips, wrinkles, and folds. Aesthetic Plast Surg 1998;22:97-101
17. Duranti F, Salti G, Bovani B, et al. Injectable hyaluronic acid gel for soft tissue augmentation. A clinical and histological study. Dermatol Surg 1998;24:1317-1325
18. Lowe NJ, Maxwell CA, Lowe P, et al. Hyaluronic acid skin fillers: adverse reactions and skin testing. J Am Acad Dermatol 2001;45:930-933
19. Micheels P. Human anti-hyaluronic acid antibodies: is it possible? Dermatol Surg 2001;27:185-191
20. Shafir R, Amir A, Gur E. Long-term complications of facial injections with Restylane (injectable hyaluronic acid). Plast Reconstr Surg 2000;106:1215-1216
21. Kavouni A, Stanec JJ. Human antihyaluronic acid antibodies. Dermatol Surg 2002;28:359-360
22. Lupton JR, Alster TS. Cutaneous hypersensitivity reaction to injectable hyaluronic acid gel. Dermatol Surg 2000;26:135-137
23. Schanz S, Schippert W, Ulmer A, et al. Arterial embolization caused by injection of hyaluronic acid (Restylane). Br J Dermatol 2002;146:928-929
24. Friedman PM, Mafong EA, Kauvar AN, Geronemus RG. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg 2002;28:491-494
25. Larsen NE, Pollak CT, Reiner K, et al. Hylan gel biomaterial: dermal and immunologic compatibility. J Biomed Mater Res 1993;27:1129-1134
26. Manna F, Dentini M, Desideri P, et al. Comparative chemical evaluation of two commercially available derivatives of hyaluronic acid (hylaform from rooster combs and restylane from streptococcus) used for soft tissue augmentation. J Eur Acad Dermatol Venereol 1999;13:183-192
27. Filion MC, Phillips NC. Pro-inflammatory activity of contaminating DNA in hyaluronic acid preparations. J Pharm Pharmacol 2001;53:555-561
28. Bergeret-Galley C, Latouche X, Illouz YG. The value of a new filler material in corrective and cosmetic surgery: DermaLive and DermaDeep. Aesthetic Plast Surg 2001;25: 249-255